Pictet Asset Management (UK)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $130M | Sell |
|
|||||
|
2021
Q1 | $118M | Sell |
|
|||||
|
2020
Q4 | $167M | Buy |
|
|||||
|
2020
Q3 | $145M | Buy |
|
|||||
|
2020
Q2 | $222M | Buy |
|
|||||
|
2020
Q1 | $93.7M | Buy |
|
|||||
|
2019
Q4 | $64.2M | Buy |
|
|||||
|
2019
Q3 | $39.7M | Sell |
|
|||||
|
2019
Q2 | $116M | Sell |
|
|||||
|
2019
Q1 | $121M | Buy |
|
|||||
|
2018
Q4 | $111K | Buy |
|
|||||
|
2018
Q3 | $118M | Sell |
|
|||||
|
2018
Q2 | $136M | Sell |
|
|||||
|
2018
Q1 | $126M | Buy |
|
|||||
|
2017
Q4 | $116M | Buy |
|
|||||
|
2017
Q3 | $106M | Buy |
|
|||||
|
2017
Q2 | $85M | Sell |
|
|||||
|
2017
Q1 | $86.4M | Sell |
|
|||||
|
2016
Q4 | $82.8M | Buy |
|
|||||
|
2016
Q3 | $82.8M | Sell |
|
|||||
|
2016
Q2 | $86.8M | Buy |
|
|||||
|
2016
Q1 | $21.7M | Sell |
|
|||||
|
2015
Q4 | $31M | Buy |
|
|||||
|
2015
Q3 | $24.9M | Sell |
|
|||||
|
2015
Q2 | $48.1M | Buy |
|
|||||
|
2015
Q1 | $30.4M | Sell |
|
|||||
|
2014
Q4 | $30.8M | Buy |
|
|||||
|
2014
Q3 | $13.5M | Sell |
|
|||||
|
2014
Q2 | $12.6M | Buy |
|
|||||
|
2014
Q1 | $11.9M | Buy |
|
|||||
|
2013
Q4 | $11.2M | Sell |
|
|||||
|
2013
Q3 | $12.8M | Sell |
|
|||||
|
2013
Q2 | $13.1M | Buy |
|